Feng Li
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Diagnosis and Treatment 9
- Sarcoma Diagnosis and Treatment 9
- Lung Cancer Treatments and Mutations 5
-
- RNA modifications and cancer 5
- Co-authors
- Kunio Doi (3 shared papers)Kenji Suzuki (1 shared paper)Kazuteru Doi (1 shared paper)S Sone (1 shared paper)K. Uéda (1 shared paper)Akira Yamada (1 shared paper)Yasunari Fujinaga (1 shared paper)Takeshi Hara (1 shared paper)
- Journals
- Oncotarget (4 papers)Journal of Ethnopharmacology (4 papers)PLoS ONE (3 papers)International Journal of Surgery (3 papers)Frontiers in Immunology (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Feng Li
147 papers receiving 2.5k citations
Feng Li's Hit Papers
Peers
Comparison fields: 5 of 129
- Otorhinolaryngology 99
- Oncology 540
- Hepatology 132
- Pulmonary and Respiratory Medicine 488
- Cancer Research 215
Countries citing papers authored by Feng Li
This map shows the geographic impact of Feng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Li more than expected).
Fields of papers citing papers by Feng Li
This network shows the impact of papers produced by Feng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Li. The network helps show where Feng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis Hit paper breakdown → | 2021 | 222 |
| 2 | 2011 | 172 | |
| 3 | 2005 | 163 | |
| 4 | 2017 | 87 | |
| 5 | 2010 | 78 | |
| 6 | 2018 | 74 | |
| 7 | 2023 | 53 | |
| 8 | 2008 | 47 | |
| 9 | 2011 | 44 | |
| 10 | 2015 | 43 | |
| 11 | 2013 | 38 | |
| 12 | 2011 | 37 | |
| 13 | 2023 | 35 | |
| 14 | 2020 | 35 | |
| 15 | 2016 | 35 | |
| 16 | 2019 | 34 | |
| 17 | 2019 | 32 | |
| 18 | 2014 | 32 | |
| 19 | 2014 | 31 | |
| 20 | 2013 | 30 |
About Feng Li
Feng Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Surgery and Pathology and Forensic Medicine, having authored 152 papers that have together received 2.5k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Diagnosis and Treatment (9 papers), Sarcoma Diagnosis and Treatment (9 papers), Immunotherapy and Immune Responses (5 papers), Lung Cancer Treatments and Mutations (5 papers), RNA modifications and cancer (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). The work is most often cited by research in Otorhinolaryngology (99 citations), Oncology (540 citations), Hepatology (132 citations), Pulmonary and Respiratory Medicine (488 citations) and Cancer Research (215 citations). Feng Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Kunio Doi, Kenji Suzuki, Kazuteru Doi, S Sone, K. Uéda, Akira Yamada, Yasunari Fujinaga, Takeshi Hara, Masumi Kadoya and Roger Engelmann. Their work appears in journals such as Oncotarget, Journal of Ethnopharmacology, PLoS ONE, International Journal of Surgery and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.